Lincoln Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals Limited has submitted a certificate to the Exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine regulatory compliance filing confirming adherence to depositary-related rules. The company has informed NSE about this submission, with no financial or operational details disclosed. No specific numbers, timelines, or business impact details were provided in the announcement.
This is a standard regulatory compliance disclosure with no direct impact on shareholders, business operations, or stock price. Investors can view this as a routine procedural update.